Global Human Rabies Vaccine Market Insights and Forecast to 2031

Report ID: 1226378 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Human Rabies Vaccine Product Introduction
    1.2 Market by Type
        1.2.1 Global Human Rabies Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Vero Cell
        1.2.3 BHK
        1.2.4 Chick Embryo Cell
        1.2.5 Human Diploid Cells
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Human Rabies Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Pre-Exposure Vaccine
        1.3.3 Post-Exposure Vaccine
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Human Rabies Vaccine Sales Estimates and Forecasts 2017-2028
    2.2 Global Human Rabies Vaccine Revenue Estimates and Forecasts 2017-2028
    2.3 Global Human Rabies Vaccine Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Human Rabies Vaccine Sales by Region
        2.4.1 Global Human Rabies Vaccine Sales by Region (2017-2022)
        2.4.2 Global Sales Human Rabies Vaccine by Region (2023-2028)
    2.5 Global Human Rabies Vaccine Revenue by Region
        2.5.1 Global Human Rabies Vaccine Revenue by Region (2017-2022)
        2.5.2 Global Human Rabies Vaccine Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Human Rabies Vaccine Sales by Manufacturers
        3.1.1 Global Top Human Rabies Vaccine Manufacturers by Sales (2017-2022)
        3.1.2 Global Human Rabies Vaccine Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Rabies Vaccine in 2021
    3.2 Global Human Rabies Vaccine Revenue by Manufacturers
        3.2.1 Global Human Rabies Vaccine Revenue by Manufacturers (2017-2022)
        3.2.2 Global Human Rabies Vaccine Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Human Rabies Vaccine Revenue in 2021
    3.3 Global Human Rabies Vaccine Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Human Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Human Rabies Vaccine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Human Rabies Vaccine Sales by Type
        4.1.1 Global Human Rabies Vaccine Historical Sales by Type (2017-2022)
        4.1.2 Global Human Rabies Vaccine Forecasted Sales by Type (2023-2028)
        4.1.3 Global Human Rabies Vaccine Sales Market Share by Type (2017-2028)
    4.2 Global Human Rabies Vaccine Revenue by Type
        4.2.1 Global Human Rabies Vaccine Historical Revenue by Type (2017-2022)
        4.2.2 Global Human Rabies Vaccine Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Human Rabies Vaccine Revenue Market Share by Type (2017-2028)
    4.3 Global Human Rabies Vaccine Price by Type
        4.3.1 Global Human Rabies Vaccine Price by Type (2017-2022)
        4.3.2 Global Human Rabies Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Human Rabies Vaccine Sales by Application
        5.1.1 Global Human Rabies Vaccine Historical Sales by Application (2017-2022)
        5.1.2 Global Human Rabies Vaccine Forecasted Sales by Application (2023-2028)
        5.1.3 Global Human Rabies Vaccine Sales Market Share by Application (2017-2028)
    5.2 Global Human Rabies Vaccine Revenue by Application
        5.2.1 Global Human Rabies Vaccine Historical Revenue by Application (2017-2022)
        5.2.2 Global Human Rabies Vaccine Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Human Rabies Vaccine Revenue Market Share by Application (2017-2028)
    5.3 Global Human Rabies Vaccine Price by Application
        5.3.1 Global Human Rabies Vaccine Price by Application (2017-2022)
        5.3.2 Global Human Rabies Vaccine Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Human Rabies Vaccine Market Size by Type
        6.1.1 North America Human Rabies Vaccine Sales by Type (2017-2028)
        6.1.2 North America Human Rabies Vaccine Revenue by Type (2017-2028)
    6.2 North America Human Rabies Vaccine Market Size by Application
        6.2.1 North America Human Rabies Vaccine Sales by Application (2017-2028)
        6.2.2 North America Human Rabies Vaccine Revenue by Application (2017-2028)
    6.3 North America Human Rabies Vaccine Market Size by Country
        6.3.1 North America Human Rabies Vaccine Sales by Country (2017-2028)
        6.3.2 North America Human Rabies Vaccine Revenue by Country (2017-2028)
        6.3.3 United States
        6.3.4 Canada
7 Europe
    7.1 Europe Human Rabies Vaccine Market Size by Type
        7.1.1 Europe Human Rabies Vaccine Sales by Type (2017-2028)
        7.1.2 Europe Human Rabies Vaccine Revenue by Type (2017-2028)
    7.2 Europe Human Rabies Vaccine Market Size by Application
        7.2.1 Europe Human Rabies Vaccine Sales by Application (2017-2028)
        7.2.2 Europe Human Rabies Vaccine Revenue by Application (2017-2028)
    7.3 Europe Human Rabies Vaccine Market Size by Country
        7.3.1 Europe Human Rabies Vaccine Sales by Country (2017-2028)
        7.3.2 Europe Human Rabies Vaccine Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Human Rabies Vaccine Market Size by Type
        8.1.1 Asia Pacific Human Rabies Vaccine Sales by Type (2017-2028)
        8.1.2 Asia Pacific Human Rabies Vaccine Revenue by Type (2017-2028)
    8.2 Asia Pacific Human Rabies Vaccine Market Size by Application
        8.2.1 Asia Pacific Human Rabies Vaccine Sales by Application (2017-2028)
        8.2.2 Asia Pacific Human Rabies Vaccine Revenue by Application (2017-2028)
    8.3 Asia Pacific Human Rabies Vaccine Market Size by Region
        8.3.1 Asia Pacific Human Rabies Vaccine Sales by Region (2017-2028)
        8.3.2 Asia Pacific Human Rabies Vaccine Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Human Rabies Vaccine Market Size by Type
        9.1.1 Latin America Human Rabies Vaccine Sales by Type (2017-2028)
        9.1.2 Latin America Human Rabies Vaccine Revenue by Type (2017-2028)
    9.2 Latin America Human Rabies Vaccine Market Size by Application
        9.2.1 Latin America Human Rabies Vaccine Sales by Application (2017-2028)
        9.2.2 Latin America Human Rabies Vaccine Revenue by Application (2017-2028)
    9.3 Latin America Human Rabies Vaccine Market Size by Country
        9.3.1 Latin America Human Rabies Vaccine Sales by Country (2017-2028)
        9.3.2 Latin America Human Rabies Vaccine Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Human Rabies Vaccine Market Size by Type
        10.1.1 Middle East and Africa Human Rabies Vaccine Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Human Rabies Vaccine Revenue by Type (2017-2028)
    10.2 Middle East and Africa Human Rabies Vaccine Market Size by Application
        10.2.1 Middle East and Africa Human Rabies Vaccine Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Human Rabies Vaccine Revenue by Application (2017-2028)
    10.3 Middle East and Africa Human Rabies Vaccine Market Size by Country
        10.3.1 Middle East and Africa Human Rabies Vaccine Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Human Rabies Vaccine Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Bharat Biotech
        11.1.1 Bharat Biotech Corporation Information
        11.1.2 Bharat Biotech Overview
        11.1.3 Bharat Biotech Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Bharat Biotech Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Bharat Biotech Recent Developments
    11.2 Bavarian Nordic
        11.2.1 Bavarian Nordic Corporation Information
        11.2.2 Bavarian Nordic Overview
        11.2.3 Bavarian Nordic Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Bavarian Nordic Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Bavarian Nordic Recent Developments
    11.3 Sanofi-Pasteur
        11.3.1 Sanofi-Pasteur Corporation Information
        11.3.2 Sanofi-Pasteur Overview
        11.3.3 Sanofi-Pasteur Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Sanofi-Pasteur Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Sanofi-Pasteur Recent Developments
    11.4 Chengda Bio
        11.4.1 Chengda Bio Corporation Information
        11.4.2 Chengda Bio Overview
        11.4.3 Chengda Bio Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Chengda Bio Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Chengda Bio Recent Developments
    11.5 KANGH
        11.5.1 KANGH Corporation Information
        11.5.2 KANGH Overview
        11.5.3 KANGH Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 KANGH Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 KANGH Recent Developments
    11.6 Prcmise
        11.6.1 Prcmise Corporation Information
        11.6.2 Prcmise Overview
        11.6.3 Prcmise Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Prcmise Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Prcmise Recent Developments
    11.7 Henan Grand Biopharma
        11.7.1 Henan Grand Biopharma Corporation Information
        11.7.2 Henan Grand Biopharma Overview
        11.7.3 Henan Grand Biopharma Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Henan Grand Biopharma Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Henan Grand Biopharma Recent Developments
    11.8 Zhuoyi Biological
        11.8.1 Zhuoyi Biological Corporation Information
        11.8.2 Zhuoyi Biological Overview
        11.8.3 Zhuoyi Biological Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Zhuoyi Biological Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Zhuoyi Biological Recent Developments
    11.9 ZhongKe Biopharm
        11.9.1 ZhongKe Biopharm Corporation Information
        11.9.2 ZhongKe Biopharm Overview
        11.9.3 ZhongKe Biopharm Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 ZhongKe Biopharm Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 ZhongKe Biopharm Recent Developments
    11.10 Ningbo Rongan Biological
        11.10.1 Ningbo Rongan Biological Corporation Information
        11.10.2 Ningbo Rongan Biological Overview
        11.10.3 Ningbo Rongan Biological Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Ningbo Rongan Biological Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Ningbo Rongan Biological Recent Developments
    11.11 Indian Immunologicals
        11.11.1 Indian Immunologicals Corporation Information
        11.11.2 Indian Immunologicals Overview
        11.11.3 Indian Immunologicals Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Indian Immunologicals Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Indian Immunologicals Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Human Rabies Vaccine Industry Chain Analysis
    12.2 Human Rabies Vaccine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Human Rabies Vaccine Production Mode & Process
    12.4 Human Rabies Vaccine Sales and Marketing
        12.4.1 Human Rabies Vaccine Sales Channels
        12.4.2 Human Rabies Vaccine Distributors
    12.5 Human Rabies Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Human Rabies Vaccine Industry Trends
    13.2 Human Rabies Vaccine Market Drivers
    13.3 Human Rabies Vaccine Market Challenges
    13.4 Human Rabies Vaccine Market Restraints
14 Key Findings in The Global Human Rabies Vaccine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Human Rabies Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Vero Cell
    Table 3. Major Manufacturers of BHK
    Table 4. Major Manufacturers of Chick Embryo Cell
    Table 5. Major Manufacturers of Human Diploid Cells
    Table 6. Major Manufacturers of Others
    Table 7. Global Human Rabies Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Human Rabies Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Human Rabies Vaccine Sales by Region (2017-2022) & (K Units)
    Table 10. Global Human Rabies Vaccine Sales Market Share by Region (2017-2022)
    Table 11. Global Human Rabies Vaccine Sales by Region (2023-2028) & (K Units)
    Table 12. Global Human Rabies Vaccine Sales Market Share by Region (2023-2028)
    Table 13. Global Human Rabies Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Human Rabies Vaccine Revenue Market Share by Region (2017-2022)
    Table 15. Global Human Rabies Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Human Rabies Vaccine Revenue Market Share by Region (2023-2028)
    Table 17. Global Human Rabies Vaccine Sales by Manufacturers (2017-2022) & (K Units)
    Table 18. Global Human Rabies Vaccine Sales Share by Manufacturers (2017-2022)
    Table 19. Global Human Rabies Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Human Rabies Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 21. Human Rabies Vaccine Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 22. Global Human Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Human Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Vaccine as of 2021)
    Table 24. Human Rabies Vaccine Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Human Rabies Vaccine Product Offered
    Table 26. Date of Manufacturers Enter into Human Rabies Vaccine Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Human Rabies Vaccine Sales by Type (2017-2022) & (K Units)
    Table 29. Global Human Rabies Vaccine Sales by Type (2023-2028) & (K Units)
    Table 30. Global Human Rabies Vaccine Sales Share by Type (2017-2022)
    Table 31. Global Human Rabies Vaccine Sales Share by Type (2023-2028)
    Table 32. Global Human Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Human Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Human Rabies Vaccine Revenue Share by Type (2017-2022)
    Table 35. Global Human Rabies Vaccine Revenue Share by Type (2023-2028)
    Table 36. Human Rabies Vaccine Price by Type (2017-2022) & (US$/Unit)
    Table 37. Global Human Rabies Vaccine Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 38. Global Human Rabies Vaccine Sales by Application (2017-2022) & (K Units)
    Table 39. Global Human Rabies Vaccine Sales by Application (2023-2028) & (K Units)
    Table 40. Global Human Rabies Vaccine Sales Share by Application (2017-2022)
    Table 41. Global Human Rabies Vaccine Sales Share by Application (2023-2028)
    Table 42. Global Human Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Human Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Human Rabies Vaccine Revenue Share by Application (2017-2022)
    Table 45. Global Human Rabies Vaccine Revenue Share by Application (2023-2028)
    Table 46. Human Rabies Vaccine Price by Application (2017-2022) & (US$/Unit)
    Table 47. Global Human Rabies Vaccine Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 48. North America Human Rabies Vaccine Sales by Type (2017-2022) & (K Units)
    Table 49. North America Human Rabies Vaccine Sales by Type (2023-2028) & (K Units)
    Table 50. North America Human Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Human Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Human Rabies Vaccine Sales by Application (2017-2022) & (K Units)
    Table 53. North America Human Rabies Vaccine Sales by Application (2023-2028) & (K Units)
    Table 54. North America Human Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Human Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Human Rabies Vaccine Sales by Country (2017-2022) & (K Units)
    Table 57. North America Human Rabies Vaccine Sales by Country (2023-2028) & (K Units)
    Table 58. North America Human Rabies Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Human Rabies Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Human Rabies Vaccine Sales by Type (2017-2022) & (K Units)
    Table 61. Europe Human Rabies Vaccine Sales by Type (2023-2028) & (K Units)
    Table 62. Europe Human Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Human Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Human Rabies Vaccine Sales by Application (2017-2022) & (K Units)
    Table 65. Europe Human Rabies Vaccine Sales by Application (2023-2028) & (K Units)
    Table 66. Europe Human Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Human Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Human Rabies Vaccine Sales by Country (2017-2022) & (K Units)
    Table 69. Europe Human Rabies Vaccine Sales by Country (2023-2028) & (K Units)
    Table 70. Europe Human Rabies Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Human Rabies Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Human Rabies Vaccine Sales by Type (2017-2022) & (K Units)
    Table 73. Asia Pacific Human Rabies Vaccine Sales by Type (2023-2028) & (K Units)
    Table 74. Asia Pacific Human Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Human Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Human Rabies Vaccine Sales by Application (2017-2022) & (K Units)
    Table 77. Asia Pacific Human Rabies Vaccine Sales by Application (2023-2028) & (K Units)
    Table 78. Asia Pacific Human Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Human Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Human Rabies Vaccine Sales by Region (2017-2022) & (K Units)
    Table 81. Asia Pacific Human Rabies Vaccine Sales by Region (2023-2028) & (K Units)
    Table 82. Asia Pacific Human Rabies Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Human Rabies Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Human Rabies Vaccine Sales by Type (2017-2022) & (K Units)
    Table 85. Latin America Human Rabies Vaccine Sales by Type (2023-2028) & (K Units)
    Table 86. Latin America Human Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Human Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Human Rabies Vaccine Sales by Application (2017-2022) & (K Units)
    Table 89. Latin America Human Rabies Vaccine Sales by Application (2023-2028) & (K Units)
    Table 90. Latin America Human Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Human Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Human Rabies Vaccine Sales by Country (2017-2022) & (K Units)
    Table 93. Latin America Human Rabies Vaccine Sales by Country (2023-2028) & (K Units)
    Table 94. Latin America Human Rabies Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Human Rabies Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Human Rabies Vaccine Sales by Type (2017-2022) & (K Units)
    Table 97. Middle East and Africa Human Rabies Vaccine Sales by Type (2023-2028) & (K Units)
    Table 98. Middle East and Africa Human Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Human Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Human Rabies Vaccine Sales by Application (2017-2022) & (K Units)
    Table 101. Middle East and Africa Human Rabies Vaccine Sales by Application (2023-2028) & (K Units)
    Table 102. Middle East and Africa Human Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Human Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Human Rabies Vaccine Sales by Country (2017-2022) & (K Units)
    Table 105. Middle East and Africa Human Rabies Vaccine Sales by Country (2023-2028) & (K Units)
    Table 106. Middle East and Africa Human Rabies Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Human Rabies Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Bharat Biotech Corporation Information
    Table 109. Bharat Biotech Description and Major Businesses
    Table 110. Bharat Biotech Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 111. Bharat Biotech Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Bharat Biotech Recent Developments
    Table 113. Bavarian Nordic Corporation Information
    Table 114. Bavarian Nordic Description and Major Businesses
    Table 115. Bavarian Nordic Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 116. Bavarian Nordic Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Bavarian Nordic Recent Developments
    Table 118. Sanofi-Pasteur Corporation Information
    Table 119. Sanofi-Pasteur Description and Major Businesses
    Table 120. Sanofi-Pasteur Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 121. Sanofi-Pasteur Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Sanofi-Pasteur Recent Developments
    Table 123. Chengda Bio Corporation Information
    Table 124. Chengda Bio Description and Major Businesses
    Table 125. Chengda Bio Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 126. Chengda Bio Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Chengda Bio Recent Developments
    Table 128. KANGH Corporation Information
    Table 129. KANGH Description and Major Businesses
    Table 130. KANGH Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 131. KANGH Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. KANGH Recent Developments
    Table 133. Prcmise Corporation Information
    Table 134. Prcmise Description and Major Businesses
    Table 135. Prcmise Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 136. Prcmise Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Prcmise Recent Developments
    Table 138. Henan Grand Biopharma Corporation Information
    Table 139. Henan Grand Biopharma Description and Major Businesses
    Table 140. Henan Grand Biopharma Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 141. Henan Grand Biopharma Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Henan Grand Biopharma Recent Developments
    Table 143. Zhuoyi Biological Corporation Information
    Table 144. Zhuoyi Biological Description and Major Businesses
    Table 145. Zhuoyi Biological Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 146. Zhuoyi Biological Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Zhuoyi Biological Recent Developments
    Table 148. ZhongKe Biopharm Corporation Information
    Table 149. ZhongKe Biopharm Description and Major Businesses
    Table 150. ZhongKe Biopharm Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 151. ZhongKe Biopharm Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. ZhongKe Biopharm Recent Developments
    Table 153. Ningbo Rongan Biological Corporation Information
    Table 154. Ningbo Rongan Biological Description and Major Businesses
    Table 155. Ningbo Rongan Biological Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 156. Ningbo Rongan Biological Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Ningbo Rongan Biological Recent Developments
    Table 158. Indian Immunologicals Corporation Information
    Table 159. Indian Immunologicals Description and Major Businesses
    Table 160. Indian Immunologicals Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 161. Indian Immunologicals Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Indian Immunologicals Recent Developments
    Table 163. Key Raw Materials Lists
    Table 164. Raw Materials Key Suppliers Lists
    Table 165. Human Rabies Vaccine Distributors List
    Table 166. Human Rabies Vaccine Customers List
    Table 167. Human Rabies Vaccine Market Trends
    Table 168. Human Rabies Vaccine Market Drivers
    Table 169. Human Rabies Vaccine Market Challenges
    Table 170. Human Rabies Vaccine Market Restraints
    Table 171. Research Programs/Design for This Report
    Table 172. Key Data Information from Secondary Sources
    Table 173. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Rabies Vaccine Product Picture
    Figure 3. Global Human Rabies Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Vero Cell Product Picture
    Figure 4. BHK Product Picture
    Figure 5. Chick Embryo Cell Product Picture
    Figure 6. Human Diploid Cells Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Human Rabies Vaccine Market Share by Application in 2021 & 2028
    Figure 9. Pre-Exposure Vaccine
    Figure 10. Post-Exposure Vaccine
    Figure 11. Human Rabies Vaccine Report Years Considered
    Figure 12. Global Human Rabies Vaccine Sales 2017-2028 (K Units)
    Figure 13. Global Human Rabies Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Human Rabies Vaccine Revenue 2017-2028 (US$ Million)
    Figure 15. Global Human Rabies Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Human Rabies Vaccine Sales Market Share by Region (2017-2022)
    Figure 17. Global Human Rabies Vaccine Sales Market Share by Region (2023-2028)
    Figure 18. North America Human Rabies Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Human Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Human Rabies Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Human Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Human Rabies Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Human Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Human Rabies Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Human Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Human Rabies Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Human Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Human Rabies Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Human Rabies Vaccine in the World: Market Share by Human Rabies Vaccine Revenue in 2021
    Figure 30. Global Human Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Human Rabies Vaccine Sales Market Share by Type (2017-2028)
    Figure 32. Global Human Rabies Vaccine Revenue Market Share by Type (2017-2028)
    Figure 33. Global Human Rabies Vaccine Sales Market Share by Application (2017-2028)
    Figure 34. Global Human Rabies Vaccine Revenue Market Share by Application (2017-2028)
    Figure 35. North America Human Rabies Vaccine Sales Market Share by Type (2017-2028)
    Figure 36. North America Human Rabies Vaccine Revenue Market Share by Type (2017-2028)
    Figure 37. North America Human Rabies Vaccine Sales Market Share by Application (2017-2028)
    Figure 38. North America Human Rabies Vaccine Revenue Market Share by Application (2017-2028)
    Figure 39. North America Human Rabies Vaccine Sales Share by Country (2017-2028)
    Figure 40. North America Human Rabies Vaccine Revenue Share by Country (2017-2028)
    Figure 41. United States Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Human Rabies Vaccine Sales Market Share by Type (2017-2028)
    Figure 44. Europe Human Rabies Vaccine Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Human Rabies Vaccine Sales Market Share by Application (2017-2028)
    Figure 46. Europe Human Rabies Vaccine Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Human Rabies Vaccine Sales Share by Country (2017-2028)
    Figure 48. Europe Human Rabies Vaccine Revenue Share by Country (2017-2028)
    Figure 49. Germany Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 50. France Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Human Rabies Vaccine Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Human Rabies Vaccine Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Human Rabies Vaccine Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Human Rabies Vaccine Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Human Rabies Vaccine Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Human Rabies Vaccine Revenue Share by Region (2017-2028)
    Figure 60. China Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 63. India Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 65. China Taiwan Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Human Rabies Vaccine Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Human Rabies Vaccine Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Human Rabies Vaccine Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Human Rabies Vaccine Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Human Rabies Vaccine Sales Share by Country (2017-2028)
    Figure 74. Latin America Human Rabies Vaccine Revenue Share by Country (2017-2028)
    Figure 75. Mexico Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Human Rabies Vaccine Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Human Rabies Vaccine Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Human Rabies Vaccine Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Human Rabies Vaccine Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Human Rabies Vaccine Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Human Rabies Vaccine Revenue Share by Country (2017-2028)
    Figure 84. Turkey Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 86. UAE Human Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 87. Human Rabies Vaccine Value Chain
    Figure 88. Human Rabies Vaccine Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals
Frequently Asked Questions
Human Rabies Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Rabies Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Rabies Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Flood Barrier

Flood Barrier market is segmented by players, region (country), by Type and by Application. Playe ... Read More